Difference between revisions of "Federal Provincial Territorial COVID-19 web management working group/August 31 2021"
Jump to navigation
Jump to search
Adey.farah (talk | contribs) (Created page with "fr:Groupe de travail federal provincial territorial sur la gestion du contenu web COVID-19/17 aout 2021 {{Template:FPT COVID web management Tabs}} ==Meeting information=...") |
Adey.farah (talk | contribs) |
||
| (8 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | [[fr:Groupe de travail federal provincial territorial sur la gestion du contenu web COVID-19/ | + | [[fr:Groupe de travail federal provincial territorial sur la gestion du contenu web COVID-19/31 août 2021]] |
{{Template:FPT COVID web management Tabs}} | {{Template:FPT COVID web management Tabs}} | ||
| − | |||
| − | |||
| − | * | + | ==Updates== |
| − | https:// | + | <b>Travel:</b> Contact Us updated on ArriveCan |
| + | *[https://voyage.gc.ca/voyage-covid/voyage-restrictions/provinces?_ga=2.38318570.839494119.1631797820-1677280738.1631797820 Restrictions provinciales et territoriales ] | ||
| + | *[https://voyage.gc.ca/voyage-covid/voyage-restrictions/visiteurs-travailleurs-etudiants?_ga=2.83416543.839494119.1631797820-1677280738.1631797820#etudiants Mises à jour faites pour les membres de la famille voyageant avec des étudiants internationaux] | ||
| − | + | <b>Vaccine:</b> Health Canada authorized Moderna for 12-17 year old (with NACI update) | |
| − | + | *Usability updates (with DTO) live on vaccine product pages (now in one page with cross links) | |
| − | + | *Updated pages: | |
| + | *[https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/astrazeneca.html AstraZeneca COVID-19 vaccine] | ||
| + | *[https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/moderna.html Moderna COVID-19 vaccine] - notice the 12 and up! | ||
| + | *[https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/pfizer-biontech.html Pfizer-BioNTech COVID-19 vaccine] | ||
| + | *[https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/vaccines/janssen.html Janssen (Johnson & Johnson) COVID-19 vaccine] | ||
| + | *Proof of vaccination page: [https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/life-after-vaccination/vaccine-proof.html COVID-19: Proof of vaccination] | ||
| − | == | + | ==Continuous improvement pages and GC design system update - TBS == |
| − | + | *Design system: [https://design.canada.ca/continuous-improvement.html Continuous improvement pages] | |
| − | + | *DTO developed guidance on what to improve, designing the content and team structure, measuring success and prototyping | |
| − | * | + | *Part of the conversation is the breadth of what is a design system |
| − | ** | + | *Design system originally came about to move all federal departments on single platform (site) and it currently has that legacy in terms of tone and lack of flexibility |
| − | + | *Paused much of the design system work until this spring, starting with what’s not working (legacy and fixed ways, fragmented documentation) and it's difficult to integrate new aspects | |
| − | + | *New team: DTO, CDS, and PP | |
| − | + | *We will continue to update at these meetings how the design system working group evolves | |
| − | + | ||
| − | + | ==Discussion items:== | |
| − | + | *Proof of vaccination | |
| + | **Quebec only province that has this up and running (update next meeting as they were unavailable) | ||
| + | **Other provinces working on this at the moment | ||
==Notes and action items== | ==Notes and action items== | ||
| − | *<b>Presentation:</b> | + | *<b>Presentation:</b> [[Media:FPT copy of GC Design System - Reviving the working group.pdf]] |
[[Category:COVID communications]] | [[Category:COVID communications]] | ||
Latest revision as of 10:57, 16 September 2021
| Home | Meetings | Collaboration space | Contacts |
Updates
Travel: Contact Us updated on ArriveCan
- Restrictions provinciales et territoriales
- Mises à jour faites pour les membres de la famille voyageant avec des étudiants internationaux
Vaccine: Health Canada authorized Moderna for 12-17 year old (with NACI update)
- Usability updates (with DTO) live on vaccine product pages (now in one page with cross links)
- Updated pages:
- AstraZeneca COVID-19 vaccine
- Moderna COVID-19 vaccine - notice the 12 and up!
- Pfizer-BioNTech COVID-19 vaccine
- Janssen (Johnson & Johnson) COVID-19 vaccine
- Proof of vaccination page: COVID-19: Proof of vaccination
Continuous improvement pages and GC design system update - TBS
- Design system: Continuous improvement pages
- DTO developed guidance on what to improve, designing the content and team structure, measuring success and prototyping
- Part of the conversation is the breadth of what is a design system
- Design system originally came about to move all federal departments on single platform (site) and it currently has that legacy in terms of tone and lack of flexibility
- Paused much of the design system work until this spring, starting with what’s not working (legacy and fixed ways, fragmented documentation) and it's difficult to integrate new aspects
- New team: DTO, CDS, and PP
- We will continue to update at these meetings how the design system working group evolves
Discussion items:
- Proof of vaccination
- Quebec only province that has this up and running (update next meeting as they were unavailable)
- Other provinces working on this at the moment
